Author

Gennie Lynne Parkman

Weber State UniversityORCID 0000-0001-9432-4353Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Paulina MedelliniD· 1 shared Adamaris Martinez· 1 shared Adriene PavekiD· 1 shared Alexandra YoungiD· 1 shared Anastasia Proveyeka· 1 shared Benjamin IzariD· 1 shared Brandon MurphyiD· 1 shared David A. KircheriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Paulina MedellinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 21, 2026

Focal adhesion kinase promotes metastasis in BRAF-mutant melanoma

Karly A. Stanley, MiKaela N. Field, Adriene Pavek…·Sheri L. Holmen

This study shows FAK promotes metastasis in BRAF-mutant melanoma through kinase-dependent mechanisms downstream of PTEN, suggesting FAK inhibition could improve treatment outcomes.

DOI 10.64898/2026.03.19.712212

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 20, 2025

Characterization of the BRAF interactome identifies BRAFV600ETP53 interaction in melanoma

Kayla T. O’Toole, Adamaris Martinez, Brandon Murphy…·Martin McMahon

The paper identifies a novel interaction between BRAFV600E and TP53 in melanoma, suggesting that BRAFV600E inactivates TP53, explaining the rarity of TP53 alterations in this cancer type.

1 citation

humanproteomics

𝕏 PostBluesky